Items per page
Sort by

Send to:

Choose Destination

Results: 18


High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.

Martin N, Borchiellini D, Coso D, Gastaud L, Boscagli A, Saudes L, Re D, Gutnecht J, Garnier G, Petit E, Barriere J, Naman H, Rossignol B, Thyss A, Peyrade F.

Leuk Lymphoma. 2015 Feb 20:1-9. [Epub ahead of print]


Management of choroidal metastases.

Jardel P, Sauerwein W, Olivier T, Bensoussan E, Maschi C, Lanza F, Mosci C, Gastaud L, Angellier G, Marcy PY, Herault J, Caujolle JP, Dendale R, Thariat J.

Cancer Treat Rev. 2014 Dec;40(10):1119-28. doi: 10.1016/j.ctrv.2014.09.006. Epub 2014 Oct 5. Review.


Hodgkin's Lymphoma in Older Patients: an Orphan Disease?

Thyss A, Saada E, Gastaud L, Peyrade F, Re D.

Mediterr J Hematol Infect Dis. 2014 Jul 1;6(1):e2014050. doi: 10.4084/MJHID.2014.050. eCollection 2014. Review.


FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.

Colavolpe C, Ebbo M, Trousse D, Khibri H, Franques J, Chetaille B, Coso D, Ouvrier MJ, Gastaud L, Guedj E, Schleinitz N.

Hematol Oncol. 2015 Jun;33(2):99-109. doi: 10.1002/hon.2140. Epub 2014 May 21.


The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Grépin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F, Pagès G.

PLoS One. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449. eCollection 2014.


[Metastasis to unusual sites].

Olivier T, Gastaud L, Maschi C, Caujolle JP, Cupissol D, Thariat J.

Bull Cancer. 2014 Feb;101(2):203-10. doi: 10.1684/bdc.2014.1889. Review. French.


Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor status.

Gastaud L, Saâda-Bouzid E, Le Morvan V, Pourquier P, Ianessi A, Thariat J, Italiano A, Thyss A.

Onkologie. 2013;36(11):670-3. doi: 10.1159/000355664. Epub 2013 Oct 14.


Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine.

Cluzeau T, Moreilhon C, Mounier N, Karsenti JM, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Auberger P, Fuzibet JG, Cassuto JP, Raynaud S.

Blood Cancer J. 2013 Nov 1;3:e155. doi: 10.1038/bcj.2013.52.


Primary multicentric angiosarcoma of bone: true entity or metastases from an unknown primary? Value of comparative genomic hybridization on paraffin embedded tissues.

Thariat J, Peyrottes I, Chibon F, Benchetrit M, Saada E, Gastaud L, Dassonville O, Iannessi A, Thyss A.

Rare Tumors. 2013 Sep 17;5(3):e53. doi: 10.4081/rt.2013.e53. eCollection 2013.


Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma.

Gastaud L, Ambrosetti D, Otto J, Marquette CH, Coutts M, Hofman P, Esnault V, Favre G.

Lung Cancer. 2013 Nov;82(2):362-4. doi: 10.1016/j.lungcan.2013.08.007. Epub 2013 Aug 15.


Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.

Cluzeau T, Mounier N, Karsenti JM, Richez V, Legros L, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Gabriel Fuzibet J, Auberger P, Raynaud S, Cassuto JP.

Am J Hematol. 2013 Sep;88(9):780-3. doi: 10.1002/ajh.23509. Epub 2013 Jul 23.


Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.

Peyrade F, Re D, Ginet C, Gastaud L, Allegra M, Ballotti R, Thyss A, Zenz T, Auberger P, Robert G.

Haematologica. 2013 Feb;98(2):e20-2. doi: 10.3324/haematol.2012.082404. Epub 2013 Jan 8. No abstract available.


Treatment decisions for elderly patients with haematological malignancies: a dilemma.

Peyrade F, Gastaud L, Ré D, Pacquelet-Cheli S, Thyss A.

Lancet Oncol. 2012 Aug;13(8):e344-52. doi: 10.1016/S1470-2045(12)70234-6. Review.


Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie JN, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau JP, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H; Acute Leukemia French Association.

Lancet. 2012 Apr 21;379(9825):1508-16. doi: 10.1016/S0140-6736(12)60485-1. Epub 2012 Apr 5.


Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease.

Thariat J, Etienne-Grimaldi MC, Launay-Vacher V, Soto-Matos A, Fernandez-Teruel C, Ghafari T, Marcy PY, Milano G, Renée N, Gastaud L, Thyss A.

Cancer Chemother Pharmacol. 2011 Nov;68(5):1363-7. doi: 10.1007/s00280-011-1718-5. Epub 2011 Aug 18.


Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

Le Gouill S, De Guibert S, Planche L, Brice P, Dupuis J, Cartron G, Van Hoof A, Casasnovas O, Gyan E, Tilly H, Fruchart C, Deconinck E, Fitoussi O, Gastaud L, Delwail V, Gabarre J, Gressin R, Blanc M, Foussard C, Salles G; GELA and GOELAMS.

Haematologica. 2011 Aug;96(8):1128-35. doi: 10.3324/haematol.2010.030320. Epub 2011 Apr 12.


Cerebellar relapse of Hodgkin lymphoma.

Thariat J, Vandenbos F, Fontaine D, Gastaud L, Peyrottes I, Thyss A.

Leuk Lymphoma. 2009 Apr;50(4):659-62. doi: 10.1080/10428190902730235. No abstract available.


Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy.

Thariat J, Italiano A, Peyrade F, Birtwisle-Peyrottes I, Gastaud L, Dassonville O, Thyss A.

Sarcoma. 2008;2008:854141. doi: 10.1155/2008/854141.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk